[1] Yu X, Gong Q, Yu D, et al. Spatial transcriptomics reveals a low extent of transcriptionally active hepatitis B virus integration in patients with HBsAg loss[J]. Gut, 2024, 73(5):797-809. [2] Yi F, Guo X, Wang L, et al. Impact of spontaneous splenorenal shunt on liver volume and long-term survival of liver cirrhosis[J]. J Gastroenterol Hepatol, 2021, 36(6):1694-1702. [3] Nickkholgh A, Wang J, Shahbazov R, et al. Intervention on spontaneous splenorenal shunt may decrease the incidence of acute kidney injury after liver transplant[J]. Exp Clin Transplant, 2020, 18(3):320-324. [4] Chen G, Li Q, Zhang Z, et al. Hemodynamic alterations with large spontaneous splenorenal shunt ligation during adult deceased donor liver transplantation[J]. Front Surg, 2022, 9:916327. [5] Yi F, Guo X, Zeng Q L, et al. Computed tomography images of spontaneous portosystemic shunt in liver cirrhosis[J]. Can J Gastroenterol Hepatol, 2022, 3231144. [6] 中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 实用肝脏病杂志, 2020, 23(1):1-24. [7] Liu G, Wang X, Luo X. Splenic arteriovenous fistula coexisting with spontaneous splenorenal shunt in a cirrhotic patient[J]. Clin Gastroenterol Hepatol, 2023, 21(10):A33. [8] Qi X, Qi X, Zhang Y, et al. Prevalence and clinical characteristics of spontaneous splenorenal shunt in liver cirrhosis: A retrospective observational study based on contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) scans[J]. Med Sci Monit, 2017, 23:2527-2534. [9] Kisaoglu A, Dandin O, Demiryilmaz I, et al. A single-center experience in portal flow augmentation in liver transplantation with prior large spontaneous splenorenal shunt[J]. Transplant Proc, 2021, 53(1):54-64. [10] Durur Karakaya A, Sorkun M, Akyıldız M, et al. Dilation of the left renal vein: an indicator of spontaneous splenorenal shunt in chronic liver disease patients[J]. Br J Radiol, 2025, 98(1169):764-769. [11] Zheng Y, Hu Q, Zhou J, et al. Evaluation of the presence and severity of spontaneous splenorenal or gastrorenal shunts via four-dimensional flow magnetic resonance imaging: a preliminary study[J]. Quant Imaging Med Surg, 2024, 14(10):7625-7639. [12] Luo X, Li J, Ma Y, et al. Albumin ratio and liver-to-abdominal area ratio are promising prognostic indicators for patients with post-hepatitis B cirrhosis[J]. Am J Transl Res, 2025, 17(8):5949-5961. [13] Caraceni P, O′Brien A, Gines P. Long-term albumin treatment in patients with cirrhosis and ascites[J]. J Hepatol, 2022, 76(6):1306-1317. [14] Garcia-Tsao G, Abraldes J G, Rich N E, et al. AGA clinical practice update on the use of vasoactive drugs and intravenous albumin in cirrhosis: expert review[J]. Gastroenterology, 2024, 166(1):202-210. [15] Achiwa S, Hirota S, Kako Y, et al. Radiological anatomy of spontaneous splenorenal shunts in patients with chronic liver disease[J]. Jpn J Radiol, 2017, 35(4):206-214. [16] Liu H, Nguyen H H, Hwang S Y, et al. Oxidative mechanisms and cardiovascular abnormalities of cirrhosis and portal hypertension[J]. Int J Mol Sci, 2023, 24(23):16805. [17] 薛文豪, 夏磊, 刘仕睿, 等. 肝硬化自发性脾肾分流的治疗与预后分析[J]. 中华普通外科杂志, 2024, 39(5):344-349. [18] García-Villarreal L, Ortega-Quevedo V, Pérez-Aguado G, et al. Massive spontaneous portosystemic shunt is a solid, easily identifiable prognostic factor in patients with cirrhosis[J]. Eur J Gastroenterol Hepatol, 2023, 35(7): 769-776. [19] Kothari R, Khanna D, Kar P. To evaluate the prevalence of spontaneous portosystemic shunts in decompensated cirrhosis patients and its prognostic significance[J]. Indian J Gastroenterol, 2023, 42(5): 677-685. |